Broadcast Retirement Network's Jeffrey Snyder discusses treatments for presbyopia with the American Academy of ...
A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for ...
The late Brien A. Holden, PhD, DSc, OAM, and colleagues recommended formal inclusion of near vision impairment in the World Health Organization’s international statistical classification of diseases ...
Trials of vision-improving substances are showing good results, though so far only two have been authorized for use in the United States.
A study of 766 patients suggested that specially formulated eye drops improved near vision for over 80% of presbyopia ...
Please provide your email address to receive an email when new articles are posted on . The first FDA-approved presbyopia-correcting IOL entered the U.S. market in 1997 when the Allergan Medical ...
A new study from Denmark showed that after taking eye drops that helps prevent longsightedness, most participants were able to focus better.
JACKSONVILLE, Fla., March 15, 2021 /PRNewswire/ -- Johnson & Johnson Vision *, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies **, today introduced a new eye ...
- Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects and affects nearly half of the U.S. adult population, ...
SHANGHAI, Sept. 2, 2021 /PRNewswire/ -- Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, today announced the clearance of the ...
SAN DIEGO -- A low-dose formulation of pilocarpine significantly improved visual acuity in presbyopia without adversely affecting distance vision, results of two randomized trials showed. As compared ...
NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback